Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK
Gespeichert in:
| Veröffentlicht in: | The Journal of hospital infection 2019-05, Vol.102 (1), p.95-97 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 97 |
|---|---|
| container_issue | 1 |
| container_start_page | 95 |
| container_title | The Journal of hospital infection |
| container_volume | 102 |
| creator | Ming, D.K. Otter, J.A. Ghani, R. Brannigan, E.T. Boonyasiri, A. Mookerjee, S. Gilchrist, M. Holmes, A.H. Davies, F. |
| description | |
| doi_str_mv | 10.1016/j.jhin.2019.01.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179508143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670119300532</els_id><sourcerecordid>2179508143</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-2a11ee2e892840d944c38e4463e1bf741bcdd679dd6a76505cf17a1a5d00fcd13</originalsourceid><addsrcrecordid>eNp9kU2PFCEQhonRuOPqH_BgOHrptqDpr8TLZlw_4upe3MQbqYbqXcZuGIEx8X_4g2Wc1aMHKFI89RbUy9hzAbUA0b3a1bs752sJYqxB1CCbB2wj2kZWcmzGh2xTLtqq60GcsScp7QCg5NvH7KyBXnSNgg37tV2cdwYXHl36xlOOmN1cEtkFz9HbsrKbXMjO8BU93tJKPvMw889vPv0Brr9eVGrgBuOEe_K0YqJqH4M9GOdv-aXPFMOEpgSHhpD4tIRgSyvClTs_kzk2S-XI8x3xm49P2aMZl0TP7uM5u3l7-WX7vrq6fvdhe3FVGQWQK4lCEEkaRjkosKNSphlIqa4hMc29EpOxtuvHsmHftdCaWfQosLUAs7GiOWcvT7rltd8PlLJeXTK0LOgpHJKWoh9bGIRqCipPqIkhpUiz3ke3YvypBeijG3qnj27ooxsahC5ulKIX9_qHaSX7r-Tv-Avw-gRQ-eUPR1En48gbsi6WqWgb3P_0fwOEDJ2V</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179508143</pqid></control><display><type>article</type><title>Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ming, D.K. ; Otter, J.A. ; Ghani, R. ; Brannigan, E.T. ; Boonyasiri, A. ; Mookerjee, S. ; Gilchrist, M. ; Holmes, A.H. ; Davies, F.</creator><creatorcontrib>Ming, D.K. ; Otter, J.A. ; Ghani, R. ; Brannigan, E.T. ; Boonyasiri, A. ; Mookerjee, S. ; Gilchrist, M. ; Holmes, A.H. ; Davies, F.</creatorcontrib><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2019.01.023</identifier><identifier>PMID: 30716340</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Anti-Bacterial Agents - administration & dosage ; beta-Lactamases - analysis ; Carbapenem-Resistant Enterobacteriaceae - enzymology ; Carbapenem-Resistant Enterobacteriaceae - isolation & purification ; Disease Management ; Drug Therapy, Combination - methods ; Enterobacteriaceae Infections - diagnosis ; Enterobacteriaceae Infections - drug therapy ; Enterobacteriaceae Infections - mortality ; Female ; Humans ; Male ; Middle Aged ; Sepsis - diagnosis ; Sepsis - drug therapy ; Sepsis - mortality ; Survival Analysis ; Treatment Outcome ; United Kingdom</subject><ispartof>The Journal of hospital infection, 2019-05, Vol.102 (1), p.95-97</ispartof><rights>2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-2a11ee2e892840d944c38e4463e1bf741bcdd679dd6a76505cf17a1a5d00fcd13</citedby><cites>FETCH-LOGICAL-c400t-2a11ee2e892840d944c38e4463e1bf741bcdd679dd6a76505cf17a1a5d00fcd13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhin.2019.01.023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30716340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ming, D.K.</creatorcontrib><creatorcontrib>Otter, J.A.</creatorcontrib><creatorcontrib>Ghani, R.</creatorcontrib><creatorcontrib>Brannigan, E.T.</creatorcontrib><creatorcontrib>Boonyasiri, A.</creatorcontrib><creatorcontrib>Mookerjee, S.</creatorcontrib><creatorcontrib>Gilchrist, M.</creatorcontrib><creatorcontrib>Holmes, A.H.</creatorcontrib><creatorcontrib>Davies, F.</creatorcontrib><title>Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><subject>Aged</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>beta-Lactamases - analysis</subject><subject>Carbapenem-Resistant Enterobacteriaceae - enzymology</subject><subject>Carbapenem-Resistant Enterobacteriaceae - isolation & purification</subject><subject>Disease Management</subject><subject>Drug Therapy, Combination - methods</subject><subject>Enterobacteriaceae Infections - diagnosis</subject><subject>Enterobacteriaceae Infections - drug therapy</subject><subject>Enterobacteriaceae Infections - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Sepsis - diagnosis</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - mortality</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>United Kingdom</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2PFCEQhonRuOPqH_BgOHrptqDpr8TLZlw_4upe3MQbqYbqXcZuGIEx8X_4g2Wc1aMHKFI89RbUy9hzAbUA0b3a1bs752sJYqxB1CCbB2wj2kZWcmzGh2xTLtqq60GcsScp7QCg5NvH7KyBXnSNgg37tV2cdwYXHl36xlOOmN1cEtkFz9HbsrKbXMjO8BU93tJKPvMw889vPv0Brr9eVGrgBuOEe_K0YqJqH4M9GOdv-aXPFMOEpgSHhpD4tIRgSyvClTs_kzk2S-XI8x3xm49P2aMZl0TP7uM5u3l7-WX7vrq6fvdhe3FVGQWQK4lCEEkaRjkosKNSphlIqa4hMc29EpOxtuvHsmHftdCaWfQosLUAs7GiOWcvT7rltd8PlLJeXTK0LOgpHJKWoh9bGIRqCipPqIkhpUiz3ke3YvypBeijG3qnj27ooxsahC5ulKIX9_qHaSX7r-Tv-Avw-gRQ-eUPR1En48gbsi6WqWgb3P_0fwOEDJ2V</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>Ming, D.K.</creator><creator>Otter, J.A.</creator><creator>Ghani, R.</creator><creator>Brannigan, E.T.</creator><creator>Boonyasiri, A.</creator><creator>Mookerjee, S.</creator><creator>Gilchrist, M.</creator><creator>Holmes, A.H.</creator><creator>Davies, F.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201905</creationdate><title>Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK</title><author>Ming, D.K. ; Otter, J.A. ; Ghani, R. ; Brannigan, E.T. ; Boonyasiri, A. ; Mookerjee, S. ; Gilchrist, M. ; Holmes, A.H. ; Davies, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-2a11ee2e892840d944c38e4463e1bf741bcdd679dd6a76505cf17a1a5d00fcd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>beta-Lactamases - analysis</topic><topic>Carbapenem-Resistant Enterobacteriaceae - enzymology</topic><topic>Carbapenem-Resistant Enterobacteriaceae - isolation & purification</topic><topic>Disease Management</topic><topic>Drug Therapy, Combination - methods</topic><topic>Enterobacteriaceae Infections - diagnosis</topic><topic>Enterobacteriaceae Infections - drug therapy</topic><topic>Enterobacteriaceae Infections - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Sepsis - diagnosis</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - mortality</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ming, D.K.</creatorcontrib><creatorcontrib>Otter, J.A.</creatorcontrib><creatorcontrib>Ghani, R.</creatorcontrib><creatorcontrib>Brannigan, E.T.</creatorcontrib><creatorcontrib>Boonyasiri, A.</creatorcontrib><creatorcontrib>Mookerjee, S.</creatorcontrib><creatorcontrib>Gilchrist, M.</creatorcontrib><creatorcontrib>Holmes, A.H.</creatorcontrib><creatorcontrib>Davies, F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ming, D.K.</au><au>Otter, J.A.</au><au>Ghani, R.</au><au>Brannigan, E.T.</au><au>Boonyasiri, A.</au><au>Mookerjee, S.</au><au>Gilchrist, M.</au><au>Holmes, A.H.</au><au>Davies, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2019-05</date><risdate>2019</risdate><volume>102</volume><issue>1</issue><spage>95</spage><epage>97</epage><pages>95-97</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30716340</pmid><doi>10.1016/j.jhin.2019.01.023</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-6701 |
| ispartof | The Journal of hospital infection, 2019-05, Vol.102 (1), p.95-97 |
| issn | 0195-6701 1532-2939 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2179508143 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Aged Anti-Bacterial Agents - administration & dosage beta-Lactamases - analysis Carbapenem-Resistant Enterobacteriaceae - enzymology Carbapenem-Resistant Enterobacteriaceae - isolation & purification Disease Management Drug Therapy, Combination - methods Enterobacteriaceae Infections - diagnosis Enterobacteriaceae Infections - drug therapy Enterobacteriaceae Infections - mortality Female Humans Male Middle Aged Sepsis - diagnosis Sepsis - drug therapy Sepsis - mortality Survival Analysis Treatment Outcome United Kingdom |
| title | Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A05%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20risk%20stratification%20and%20antibiotic%20management%20of%20NDM%20and%20OXA-48%20carbapenemase-producing%20Enterobacteriaceae%20bloodstream%20infections%20in%20the%20UK&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Ming,%20D.K.&rft.date=2019-05&rft.volume=102&rft.issue=1&rft.spage=95&rft.epage=97&rft.pages=95-97&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2019.01.023&rft_dat=%3Cproquest_cross%3E2179508143%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179508143&rft_id=info:pmid/30716340&rft_els_id=S0195670119300532&rfr_iscdi=true |